Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Poly(2-oxazoline)s based biomaterials: A comprehensive and critical update.

Lorson T, Lübtow MM, Wegener E, Haider MS, Borova S, Nahm D, Jordan R, Sokolski-Papkov M, Kabanov AV, Luxenhofer R.

Biomaterials. 2018 Sep;178:204-280. doi: 10.1016/j.biomaterials.2018.05.022. Epub 2018 Jun 2.

PMID:
29945064
2.

Nanoformulation of Brain-Derived Neurotrophic Factor with Target Receptor-Triggered-Release in the Central Nervous System.

Jiang Y, Fay JM, Poon CD, Vinod N, Zhao Y, Bullock K, Qin S, Manickam DS, Yi X, Banks WA, Kabanov AV.

Adv Funct Mater. 2018 Feb 7;28(6). pii: 1703982. doi: 10.1002/adfm.201703982. Epub 2017 Dec 7.

PMID:
29785179
3.

In Situ Observation of Chymotrypsin Catalytic Activity Change Actuated by Nonheating Low-Frequency Magnetic Field.

Efremova MV, Veselov MM, Barulin AV, Gribanovsky SL, Le-Deygen IM, Uporov IV, Kudryashova EV, Sokolsky-Papkov M, Majouga AG, Golovin YI, Kabanov AV, Klyachko NL.

ACS Nano. 2018 Apr 24;12(4):3190-3199. doi: 10.1021/acsnano.7b06439. Epub 2018 Apr 2.

PMID:
29570975
4.

Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer.

Wan X, Min Y, Bludau H, Keith A, Sheiko SS, Jordan R, Wang AZ, Sokolsky-Papkov M, Kabanov AV.

ACS Nano. 2018 Mar 27;12(3):2426-2439. doi: 10.1021/acsnano.7b07878. Epub 2018 Mar 16.

5.

Engineering macrophage-derived exosomes for targeted paclitaxel delivery to pulmonary metastases: in vitro and in vivo evaluations.

Kim MS, Haney MJ, Zhao Y, Yuan D, Deygen I, Klyachko NL, Kabanov AV, Batrakova EV.

Nanomedicine. 2018 Jan;14(1):195-204. doi: 10.1016/j.nano.2017.09.011. Epub 2017 Oct 2.

PMID:
28982587
6.

Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signaling.

Natarajan G, Perriotte-Olson C, Bhinderwala F, Powers R, Desouza CV, Talmon GA, Yuhang J, Zimmerman MC, Kabanov AV, Saraswathi V.

Transl Res. 2017 Oct;188:10-26. doi: 10.1016/j.trsl.2017.08.002. Epub 2017 Aug 15.

PMID:
28867395
7.

Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain.

Yuan D, Zhao Y, Banks WA, Bullock KM, Haney M, Batrakova E, Kabanov AV.

Biomaterials. 2017 Oct;142:1-12. doi: 10.1016/j.biomaterials.2017.07.011. Epub 2017 Jul 10.

PMID:
28715655
8.

Macrophages with cellular backpacks for targeted drug delivery to the brain.

Klyachko NL, Polak R, Haney MJ, Zhao Y, Gomes Neto RJ, Hill MC, Kabanov AV, Cohen RE, Rubner MF, Batrakova EV.

Biomaterials. 2017 Sep;140:79-87. doi: 10.1016/j.biomaterials.2017.06.017. Epub 2017 Jun 18.

9.

Pharmacokinetic and screening studies of the interaction between mononuclear phagocyte system and nanoparticle formulations and colloid forming drugs.

Lucas AT, Herity LB, Kornblum ZA, Madden AJ, Gabizon A, Kabanov AV, Ajamie RT, Bender DM, Kulanthaivel P, Sanchez-Felix MV, Havel HA, Zamboni WC.

Int J Pharm. 2017 Jun 30;526(1-2):443-454. doi: 10.1016/j.ijpharm.2017.04.079. Epub 2017 May 2.

PMID:
28473237
10.

Intranasal delivery of N-terminal modified leptin-pluronic conjugate for treatment of obesity.

Yuan D, Yi X, Zhao Y, Poon CD, Bullock KM, Hansen KM, Salameh TS, Farr SA, Banks WA, Kabanov AV.

J Control Release. 2017 Oct 10;263:172-184. doi: 10.1016/j.jconrel.2017.03.029. Epub 2017 Mar 24.

PMID:
28344017
11.

A simple and highly effective catalytic nanozyme scavenger for organophosphorus neurotoxins.

Efremenko EN, Lyagin IV, Klyachko NL, Bronich T, Zavyalova NV, Jiang Y, Kabanov AV.

J Control Release. 2017 Feb 10;247:175-181. doi: 10.1016/j.jconrel.2016.12.037. Epub 2016 Dec 31.

PMID:
28043864
12.

RECOPE: How to succeed in bringing ideas from academia to market without compromising ingenuity.

Gaymalov Z, Kabanov A.

Nanomedicine. 2017 Apr;13(3):795-800. doi: 10.1016/j.nano.2016.10.007. Epub 2016 Oct 29.

PMID:
27989854
13.

ATR maintains chromosomal integrity during postnatal cerebellar neurogenesis and is required for medulloblastoma formation.

Lang PY, Nanjangud GJ, Sokolsky-Papkov M, Shaw C, Hwang D, Parker JS, Kabanov AV, Gershon TR.

Development. 2016 Nov 1;143(21):4038-4052.

14.

Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.

Harris NM, Ritzel R, Mancini NS, Jiang Y, Yi X, Manickam DS, Banks WA, Kabanov AV, McCullough LD, Verma R.

Pharmacol Biochem Behav. 2016 Nov - Dec;150-151:48-56. doi: 10.1016/j.pbb.2016.09.003. Epub 2016 Sep 13.

15.

VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells.

Shein SA, Kuznetsov II, Abakumova TO, Chelushkin PS, Melnikov PA, Korchagina AA, Bychkov DA, Seregina IF, Bolshov MA, Kabanov AV, Chekhonin VP, Nukolova NV.

Mol Pharm. 2016 Nov 7;13(11):3712-3723. Epub 2016 Oct 3.

PMID:
27654150
16.

Remote Actuation of Magnetic Nanoparticles For Cancer Cell Selective Treatment Through Cytoskeletal Disruption.

Master AM, Williams PN, Pothayee N, Pothayee N, Zhang R, Vishwasrao HM, Golovin YI, Riffle JS, Sokolsky M, Kabanov AV.

Sci Rep. 2016 Sep 20;6:33560. doi: 10.1038/srep33560.

17.

A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity.

He Z, Wan X, Schulz A, Bludau H, Dobrovolskaia MA, Stern ST, Montgomery SA, Yuan H, Li Z, Alakhova D, Sokolsky M, Darr DB, Perou CM, Jordan R, Luxenhofer R, Kabanov AV.

Biomaterials. 2016 Sep;101:296-309. doi: 10.1016/j.biomaterials.2016.06.002. Epub 2016 Jun 4.

18.

Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers.

Mahajan V, Gaymalov Z, Alakhova D, Gupta R, Zucker IH, Kabanov AV.

Data Brief. 2016 Apr 1;7:1269-82. doi: 10.1016/j.dib.2016.03.087. eCollection 2016 Jun.

19.

SOD1 nanozyme with reduced toxicity and MPS accumulation.

Jiang Y, Arounleut P, Rheiner S, Bae Y, Kabanov AV, Milligan C, Manickam DS.

J Control Release. 2016 Jun 10;231:38-49. doi: 10.1016/j.jconrel.2016.02.038. Epub 2016 Feb 27.

PMID:
26928528
20.

Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.

Kost OA, Beznos OV, Davydova NG, Manickam DS, Nikolskaya II, Guller AE, Binevski PV, Chesnokova NB, Shekhter AB, Klyachko NL, Kabanov AV.

Oxid Med Cell Longev. 2015;2015:5194239. doi: 10.1155/2016/5194239. Epub 2015 Dec 1.

Supplemental Content

Loading ...
Support Center